Daniel Gerritzen Sells 8,614 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) General Counsel Daniel Gerritzen sold 8,614 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $17.25, for a total transaction of $148,591.50. Following the completion of the sale, the general counsel directly owned 149,533 shares of the company’s stock, valued at $2,579,444.25. The trade was a 5.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

OrthoPediatrics Stock Performance

Shares of KIDS stock opened at $16.66 on Thursday. The firm has a market cap of $421.16 million, a price-to-earnings ratio of -9.86 and a beta of 1.07. The company’s 50 day moving average is $17.67 and its 200 day moving average is $17.93. The company has a quick ratio of 2.65, a current ratio of 5.55 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 52-week low of $15.28 and a 52-week high of $26.40.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Thursday, February 26th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.11. The company had revenue of $61.61 million during the quarter, compared to analyst estimates of $61.27 million. OrthoPediatrics had a negative return on equity of 6.70% and a negative net margin of 16.77%. On average, sell-side analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Institutional Trading of OrthoPediatrics

A number of institutional investors have recently made changes to their positions in the business. Russell Investments Group Ltd. grew its stake in OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after buying an additional 1,139 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after buying an additional 2,561 shares during the last quarter. Caption Management LLC purchased a new stake in OrthoPediatrics in the third quarter valued at about $54,000. BNP Paribas Financial Markets boosted its holdings in OrthoPediatrics by 60.2% in the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after acquiring an additional 1,235 shares in the last quarter. Finally, State of Wyoming boosted its holdings in OrthoPediatrics by 189.7% in the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after acquiring an additional 4,467 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on KIDS shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OrthoPediatrics in a research report on Thursday, January 22nd. Truist Financial boosted their target price on shares of OrthoPediatrics from $19.00 to $20.00 and gave the stock a “hold” rating in a report on Monday, March 2nd. BTIG Research increased their price target on shares of OrthoPediatrics from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Needham & Company LLC raised their price target on shares of OrthoPediatrics from $26.00 to $30.00 and gave the company a “buy” rating in a report on Friday, February 27th. Finally, Wall Street Zen raised shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a research report on Saturday, March 7th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $24.67.

Trending Headlines about OrthoPediatrics

Here are the key news stories impacting OrthoPediatrics this week:

• Negative Sentiment: CEO David R. Bailey sold 19,535 shares (~$336,979), reducing his direct stake by ~6.15%. SEC Filing
• Negative Sentiment: CFO Fred Hite sold 12,993 shares (~$224,129), trimming his holding by ~4.47%. SEC Filing
• Negative Sentiment: General Counsel Daniel J. Gerritzen sold 8,614 shares (~$148,592), cutting his stake by ~5.45%. SEC Filing
• Negative Sentiment: Insider Gregory A. Odle sold 8,433 shares (~$145,469), reducing his position by ~4.30%. SEC Filing
• Negative Sentiment: Insider Joseph W. Hauser sold 8,596 shares (~$148,281), decreasing his stake by ~4.23%. SEC Filing

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.